Search research articles
Contact Us
Filters
Showing results (11-20 of 85) with videos related to
Page
of 9
Sort By:
Pharmacological Research
|
December 17, 2009
Non-viral nanosystems for systemic siRNA delivery
Stephanie David, Bruno Pitard, Jean-Pierre Benoît, et al.
Pharmacological Research
|
February 23, 2017
Nanomedicine as a potent strategy in melanoma tumor microenvironment
Vincent Pautu, Daniela Leonetti, Elise Lepeltier, et al.
Advanced Drug Delivery Reviews
|
January 3, 2021
Microbiota and cancer: In vitro and in vivo models to evaluate nanomedicines
Abdallah Ladaycia, Brigitta Loretz, Catherine Passirani, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
February 15, 2022
Modulating undruggable targets to overcome cancer therapy resistance
Catherine Passirani, Anne Vessières, Giuseppe La Regina, et al.
Biomaterials
|
May 24, 2008
Progress in developing cationic vectors for non-viral systemic gene therapy against cancer
Marie Morille, Catherine Passirani, Arnaud Vonarbourg, et al.
Drug Development and Industrial Pharmacy
|
January 8, 2013
Aqueous core nanocapsules: a new solution for encapsulating doxorubicin hydrochloride
Sandy Vrignaud, Nicolas Anton, Catherine Passirani, et al.
Biomaterials
|
June 4, 2013
A review of the current status of siRNA nanomedicines in the treatment of cancer
Pauline Resnier, Tristan Montier, Véronique Mathieu, et al.
Nanomedicine (London, England)
|
December 7, 2010
The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting
Ngoc Trinh Huynh, Emilie Roger, Nolwenn Lautram, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 24, 2004
Serum-stable and long-circulating, PEGylated, pH-sensitive liposomes
Emmanuelle Roux, Catherine Passirani, Stefanie Scheffold, et al.
Biomaterials
|
January 24, 2016
Nano and microcarriers to improve stem cell behaviour for neuroregenerative medicine strategies: Application to Huntington's disease
Emilie M André, Catherine Passirani, Begona Seijo, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 85) with videos related to
Sort By:
Page
of 9
Pharmacological Research
|
December 17, 2009
Non-viral nanosystems for systemic siRNA delivery
Stephanie David, Bruno Pitard, Jean-Pierre Benoît, et al.
Pharmacological Research
|
February 23, 2017
Nanomedicine as a potent strategy in melanoma tumor microenvironment
Vincent Pautu, Daniela Leonetti, Elise Lepeltier, et al.
Advanced Drug Delivery Reviews
|
January 3, 2021
Microbiota and cancer: In vitro and in vivo models to evaluate nanomedicines
Abdallah Ladaycia, Brigitta Loretz, Catherine Passirani, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
February 15, 2022
Modulating undruggable targets to overcome cancer therapy resistance
Catherine Passirani, Anne Vessières, Giuseppe La Regina, et al.
Biomaterials
|
May 24, 2008
Progress in developing cationic vectors for non-viral systemic gene therapy against cancer
Marie Morille, Catherine Passirani, Arnaud Vonarbourg, et al.
Drug Development and Industrial Pharmacy
|
January 8, 2013
Aqueous core nanocapsules: a new solution for encapsulating doxorubicin hydrochloride
Sandy Vrignaud, Nicolas Anton, Catherine Passirani, et al.
Biomaterials
|
June 4, 2013
A review of the current status of siRNA nanomedicines in the treatment of cancer
Pauline Resnier, Tristan Montier, Véronique Mathieu, et al.
Nanomedicine (London, England)
|
December 7, 2010
The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting
Ngoc Trinh Huynh, Emilie Roger, Nolwenn Lautram, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 24, 2004
Serum-stable and long-circulating, PEGylated, pH-sensitive liposomes
Emmanuelle Roux, Catherine Passirani, Stefanie Scheffold, et al.
Biomaterials
|
January 24, 2016
Nano and microcarriers to improve stem cell behaviour for neuroregenerative medicine strategies: Application to Huntington's disease
Emilie M André, Catherine Passirani, Begona Seijo, et al.
Page
of 9